Minimally Invasive Circulatory Assist Devices
Product Summary
Second Heart is developing a minimally invasive circulatory support platform based on proprietary aortic stent pump technology. The platform will be deployed using low profile catheter-based techniques and will provide either temporary or chronic circulatory support, depending on the specific needs of the patient. Second Heart’s initial product will be a catheter-based temporary assist pump to treat patients with acute decompensated heart failure and to provide circulatory support to those undergoing high-risk percutaneous coronary intervention (PCI). The second application will be a wirelessly powered circulatory assist pump that will provide chronic circulatory support for heart failure patients.
Key features of Second Heart’s platform include:
- A higher flow (with lower RPMs) rate than other systems at over 7 liters per minute.
- Pump placement just above the renal arteries will provide additional benefit for heart failure patients with kidney dysfunction.
- A choice of pulsatile or continuous flow to optimize hemodynamics and lessen the risk of thrombosis.
- The only system to use the full inner diameter of the aorta to increase pump stability and reduce pump migration.
- Lower risk of mechanical failure due to simple impeller deployment mechanism, improved bearings, and liquid cooled drive shaft.
Latest News
OUR TEAM
Alex Richardson
VP Engineering & Product Development
Asli Gozoren
Chief Advisor, Investor Relations
Brittany Brown
Board Director
Dinesh Patel
Board Director
Howard Leonhardt
Chairman, CEO
Jane Reedy
Chief Advisor Clinical Affairs
Jeff Donofrio
President
Ken Evans
VP Corporate Development, Board Director
Kurt Kruger
Chief Advisor Biomedical Engineering & Finance
Larry Stevens
Chief Advisor Regulatory Affairs
Leslie Miller
Chief Medical Officer
Mark Cunningham
Chief Advisor CardioThoracic Surgery
Nic Chronos
Chief Advisor Research
Todd Seiger
Chief Advisor Reimbursement
Tom Newman
Associate Director Physician Relations